Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Debt / NOTE 1.250% 5/0
-
Market price (% of par)
-
69.99%
-
Total 13F principal
-
$293,785,000
-
Principal change
-
+$2,125,000
-
Total reported market value
-
$203,302,654
-
Number of holders
-
21
-
Value change
-
+$2,085,587
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 1.250% 5/0 as of Q3 2020
As of 30 Sep 2020,
CLOVIS ONCOLOGY INC - NOTE 1.250% 5/0 was held by
21 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$293,785,000
in principal (par value) of the bond.
The largest 10 bondholders included
FARALLON CAPITAL MANAGEMENT LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, Antara Capital LP, Allianz Asset Management GmbH, UBS OCONNOR LLC, D. E. Shaw & Co., Inc., CITIGROUP INC, CAPSTONE INVESTMENT ADVISORS, LLC, and Empyrean Capital Partners, LP.
This page lists
21
institutional bondholders reporting positions
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.